Title |
Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective
|
---|---|
Published in |
Frontiers in Pharmacology, September 2015
|
DOI | 10.3389/fphar.2015.00205 |
Pubmed ID | |
Authors |
Alan Talevi |
Abstract |
Multi-target drugs have raised considerable interest in the last decade owing to their advantages in the treatment of complex diseases and health conditions linked to drug resistance issues. Prospective drug repositioning to treat comorbid conditions is an additional, overlooked application of multi-target ligands. While medicinal chemists usually rely on some version of the lock and key paradigm to design novel therapeutics, modern pharmacology recognizes that the mid- and long-term effects of a given drug on a biological system may depend not only on the specific ligand-target recognition events but also on the influence of the repeated administration of a drug on the cell gene signature. The design of multi-target agents usually imposes challenging restrictions on the topology or flexibility of the candidate drugs, which are briefly discussed in the present article. Finally, computational strategies to approach the identification of novel multi-target agents are overviewed. |
![](/details/assets/components/timeline_promo/Chart-small-64d94c38d69f046c3ba53a2d94fbe59735ff15de00151846a6c730aad58629ed.png)
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 5 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 3 | 1% |
South Africa | 1 | <1% |
Unknown | 295 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 59 | 20% |
Student > Master | 42 | 14% |
Student > Bachelor | 39 | 13% |
Researcher | 37 | 12% |
Other | 10 | 3% |
Other | 41 | 14% |
Unknown | 71 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 60 | 20% |
Biochemistry, Genetics and Molecular Biology | 48 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 33 | 11% |
Agricultural and Biological Sciences | 24 | 8% |
Medicine and Dentistry | 14 | 5% |
Other | 22 | 7% |
Unknown | 98 | 33% |